Prostate Cancer Resources
The following is a list of prostate cancer resources and Web sites that you might find helpful. Also included are the primary references we used to write the Prostate Cancer Screening and Risk Assessment and related information. When you click on a link, your browser will launch a new window, and you'll be visiting a third-party site. To return to RealAge, simply close the new window.
General Information
Primary Articles
Cancer screening. Degrees of proof and practical application. Hulka, B. S., Cancer 1988 Oct 15;62(8 Suppl):1776-1780.
A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. Fleming, C., Wasson, J. H., Albertsen, P. C., Barry, M. J., Wennberg, J. E ., Journal of the American Medical Association 1993 May 26;269(20):2650-2658.
Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians. Coley, C. M., Barry, M. J., Fleming, C., Mulley, A. G., Annals of Internal Medicine 1997 Mar 1;126(5):394-406.
Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians. Coley, C. M., Barry, M. J., Fleming, C., Fahs, M. C., Mulley, A. G., Annals of Internal Medicine 1997 Mar 15;126(6):468-479.
Erectile functioning of men treated for prostate carcinoma. Robinson, J. W., Dufour, M. S., Fung, T. S., Cancer 1997 Feb 1;79(3):538-544.
High-meat diets and cancer risk. Bingham, S. A., Proceedings of the Nutrition Society 1999 May;58(2):243-248.
Intake of carotenoids and retinol in relation to risk of prostate cancer. Giovannucci, E., Ascherio, A., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Willett, W. C., Journal of the National Cancer Institute 1995 Dec 6;87(23):1767-1776.
Prostate cancer: are we screening and treating too much?. Middleton, R. G., Annals of Internal Medicine 1997 Mar 15;126(6):465-467.
Prostate cancer screening: promise and peril -- a review. Godley, P. A., Cancer Detection and Prevention 1999;23(4):316-324.
Repeat ultrasound guided prostate needle biopsy: use of free-to-total prostate specific antigen ratio in predicting prostatic carcinoma. Letran, J. L., Blase, A. B., Loberiza, F. R., Meyer, G. E., Ransom, S. D., Brawer, M. K., Journal of Urology 1998 Aug;160(2):426-429.
Screening for prostate cancer. A decision analytic view. Krahn, M. D., Mahoney, J. E., Eckman, M. H., Trachtenberg, J., Pauker, S. G., Detsky, A. S., Journal of the American Medical Association 1994 Sep 14;272(10):773-780.
Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. Oesterling, J. E., Jacobsen, S. J., Chute, C. G., Guess, H. A., Girman, C. J., Panser, L. A., Lieber, M. M., Journal of the American Medical Association 1993 Aug 18;270(7):860-864.
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. Catalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Flanigan, R. C., Patel, A., Richie, J. P., deKernion, J. B., Walsh, P. C., Scardino, P. T., Lange, P. H., Subong, E. N., Parson, R. E., Gasior, G. H., Loveland, K. G., Southwick, P. C., Journal of the American Medical Association 1998 May 20;279(19):1542-1547.
